Sg3 Management, LLC Acadia Pharmaceuticals Inc Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $2.63 Million - $3.45 Million	-125,500 Reduced 77.95%	35,500 $860,000
Q4 2021 Feb 15, 2022	BUY	$16.79 - $27.09 $2.45 Million - $3.96 Million	146,000 Added 973.33%	161,000 $3.76 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $236,700 - $371,550	15,000 New	15,000 $249,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $194,000 - $274,200	-10,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $250,200 - $549,900	10,000 New	10,000 $258,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.